Search Results - Reuben Benjamin

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Allogeneic CAR-T Cells: More than Ease of Access? by Charlotte Graham, Agnieszka Jozwik, Andrea Pepper, Reuben Benjamin

    Published in Cells (2018-10-01)
    Get full text
    Article


  2. 2

    CAR-T cells containing CD28 versus 4-1BB co-stimulatory domains show distinct metabolic profiles in patients by Molly S. Cook, Ellen King, Katie R. Flaherty, Khadiza Siddika, Sophie Papa, Reuben Benjamin, Anna Schurich

    Published in Cell Reports (2025-07-01)
    Get full text
    Article


  3. 3

    High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T‐cell therapy for large B‐cell lymphoma by Maeve A. O'Reilly, Lorna Neill, Simon M. Collin, Neil Stone, Deborah Springell, Jeremy Mensah, Kathleen P. L. Cheok, Katarzyna Jalowiec, Reuben Benjamin, Andrea Kuhnl, Claire Roddie, Robin Sanderson

    Published in HemaSphere (2024-01-01)
    Get full text
    Article


  4. 4

    Human Herpesvirus 6 Encephalitis Following Axicabtagene Ciloleucel Treatment for Refractory Diffuse Large B Cell Lymphoma by Mili Shah, Andrea Kuhnl, Gregory Shields, Malur Sudhanva, Victoria Metaxa, Shu Wong, Deborah Yallop, Piers Patten, Shafqat Inam, Catherine Hockings, Orla Stewart, Reuben Benjamin, Kirsty Cuthill, Antonio Pagliuca, Victoria Potter, Robin Sanderson

    Published in HemaSphere (2021-03-01)
    Get full text
    Article


  5. 5

    Language dysfunction-associated EEG findings in patients with CAR-T related neurotoxicity by Elisaveta Sokolov, Philipp Karschnia, Reuben Benjamin, Robert D M Hadden, Robert C D Elwes, Lee Drummond, Devyani Amin, Vitor Paiva, Alex Pennisi, Aline Herlopian, Matthew Frigault, Robin Sanderson, Jorg Dietrich, Shafqat Inam, Andrew J Cole

    Published in BMJ Neurology Open (2020-07-01)
    Get full text
    Article


  6. 6

    P866: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): KARMMA-3 SUBGROUP ANALYSIS... by Salomon Manier, Paula Rodríguez-Otero, Maria-Victoria Mateos, Hermann Einsele, Nizar J Bahlis, Nikhil Munshi, Sikander Ailawadhi, Bertrand Arnulf, Ajay Nooka, Ravi Vij, Ingerid Weum Abrahamsen, Annemiek Broijl, Sundar Jagannath, Reuben Benjamin, Usama Gergis, Douglas W. Sborov, Shinsuke Iida, Anna Truppel-Hartmann, Zhihong Yang, Julia Piasecki, Jasper Felten, Andrea Caia, Mark Cook, Rachid Baz

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  7. 7

    P904: LOCOMMOTION: A PROSPECTIVE, OBSERVATIONAL, MULTINATIONAL STUDY OF REAL-LIFE CURRENT STANDARDS OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA– FINAL ANALYSIS AT... by Philippe Moreau, Katja Weisel, Valerio De Stefano, Hartmut Goldschmidt, Michel Delforge, Mohamad Mohty, Joanne Lindsey-Hill, Dominik Dytfeld, Emanuele Angelucci, Laure Vincent, Aurore Perrot, Reuben Benjamin, Niels W.C.J. van de Donk, Enrique Ocio, Ester in ‘t Groen-Damen, Tito Roccia, Jordan Schecter, Imene Haddad, Vadim Strulev, Lada Mitchell, Jozefien Buyze, Silva Saarinen, Octavio Costa Filho, Hermann Einsele, Maria-Victoria Mateos

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  8. 8

    Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3 by Laura Tornatore, Daria Capece, Daniel D'Andrea, Federica Begalli, Daniela Verzella, Jason Bennett, Gary Acton, Elizabeth A. Campbell, James Kelly, Michael Tarbit, Nigel Adams, Selina Bannoo, Antonio Leonardi, Annamaria Sandomenico, Domenico Raimondo, Menotti Ruvo, Angela Chambery, Metod Oblak, Magda J. Al-Obaidi, Richard S. Kaczmarski, Ian Gabriel, Heather E. Oakervee, Martin F. Kaiser, Ashutosh Wechalekar, Reuben Benjamin, Jane F. Apperley, Holger W. Auner, Guido Franzoso

    Published in Toxicology Reports (2019-01-01)
    Get full text
    Article


  9. 9

    P1211: TUMOR-ACTIVATED LYMPH NODE FIBROBLASTS SUPPRESS T CELL FUNCTION IN DIFFUSE LARGE B CELL LYMPHOMA by Benedetta Apollonio, Filomena Spada, Nedyalko Petrov, Domenico Cozzetto, Peter Jarvis, Despoina Papazoglou, Shichina Kannambath, Manuela Terranova-Barberio, Rose-Marie Amini, Gunilla Enblad, Charlotte Graham, Reuben Benjamin, Elizabeth H. Phillips, Richard Ellis, Rosamond Nuamah, Mansoor Saqi, Dinis Calado, Richard Rosenquist, Lesley Ann Sutton, Jon Salisbury, Georgios Zacharioudakis, Anna Vardi, Patrick Hagner, Anita Gandhi, Marina Bacac, Christina Claus, Pablo Umana, Ruth Jarrett, Christian Klein, Alexander Deutsch, Alan Ramsay

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  10. 10

    Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma by Benedetta Apollonio, Filomena Spada, Nedyalko Petrov, Domenico Cozzetto, Despoina Papazoglou, Peter Jarvis, Shichina Kannambath, Manuela Terranova-Barberio, Rose-Marie Amini, Gunilla Enblad, Charlotte Graham, Reuben Benjamin, Elisabeth Phillips, Richard Ellis, Rosamond Nuamah, Mansoor Saqi, Dinis P. Calado, Richard Rosenquist, Lesley A. Sutton, Jon Salisbury, Georgios Zacharioudakis, Anna Vardi, Patrick R. Hagner, Anita K. Gandhi, Marina Bacac, Christina Claus, Pablo Umana, Ruth F. Jarrett, Christian Klein, Alexander Deutsch, Alan G. Ramsay

    Published in The Journal of Clinical Investigation (2023-07-01)
    Get full text
    Article


Search Tools: